Healthcare DIVE November 6, 2024
Rebecca Pifer

An unsuccessful struggle with elevated medical costs has defined 2024 for CVS. The third quarter was no different.

Dive Brief:

  • CVS reported mixed third-quarter results shadowed by heightened medical costs on Wednesday, in the massive healthcare enterprise’s first earnings report with new CEO David Joyner at the helm.
  • The Woonsocket, Rhode Island-based company beat Wall Street expectations on revenue of $95.4 billion, up more than 6% year over year. However, CVS’ net income fell to $71 million, down from almost $2.3 billion same time last year, as its Aetna insurance arm continued to struggle with higher spending.
  • CVS appointed Steve Nelson, previously the CEO of value-based primary care company ChenMed, as president of Aetna. Nelson also ran UnitedHealthcare, the...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

Continue Reading

 
Topics: Insurance, Payer
Related Articles:
AI-Driven Prior Authorization Denials Raise Concerns Among Physicians, AMA Survey Reveals
STAT+: UnitedHealth buyouts, and drug pricing spreads
Massive study on medical conditions and spending aims to fill in knowledge gaps about U.S. health care
Humana looks to deepen meaning of 'value-based care'
Fighting back against claim denials: How AI can empower physicians and patients

Share This Article